More tools:Markets·Screener·Research·Chat

Novo-Nordisk A/S (NVO) Financial Statements

Novo-Nordisk A/S
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S5TSK0
XNYS · usd
44.82▼ 0.34 (-0.75%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close45.16
Day's Range45.15 – 45.91
52-Week Range35.12 – 64.17
Volume10.3M
Avg Volume12.5M
Share Statistics
Shares Outstanding
Employees69.5K
ExchangeXNYS
Listed1981-04-30
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Novo-Nordisk A/S (NVO)
What is Novo-Nordisk A/S's Market Cap?
Novo-Nordisk A/S's Market Cap is $200.1B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Enterprise Value?
Novo-Nordisk A/S's Enterprise Value is $218.4B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Trailing P/E?
Novo-Nordisk A/S's Trailing P/E is 12.4×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Price / Sales?
Novo-Nordisk A/S's Price / Sales is 4.1×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's EV / Revenue?
Novo-Nordisk A/S's EV / Revenue is 4.5×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's EV / EBITDA?
Novo-Nordisk A/S's EV / EBITDA is 10.0×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Revenue (TTM)?
Novo-Nordisk A/S's Revenue (TTM) is $48.6B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Net Income (TTM)?
Novo-Nordisk A/S's Net Income (TTM) is $16.1B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's EBITDA?
Novo-Nordisk A/S's EBITDA is $22.4B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Diluted EPS (TTM)?
Novo-Nordisk A/S's Diluted EPS (TTM) is 3.60, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Profit or loss [abstract]
Net sales
Cost of goods sold
Gross profit
Sales and distribution costs
Research and development costs
Administrative costs
Other operating income and expenses
Operating profit
Financial income
Financial expenses
Profit before income taxes
Income taxes
Net profit
Earnings per share
Basic earnings per share (DKK per share)
Diluted earnings per share (DKK per share)